FDA Clearance Tracker · P140033
Assurity MRI and Endurity MRI Pacemakers, Tendril MRI Lead, MRI Activator, Merlin PCS Programer Software
Last checked: Nov 19, 2026Latest source record: Jan 31, 2017 (this decision)Source: openFDAMethods & limitations
Decided
Jan 31, 2017
Approved
Time to decision
769 days
Received Dec 24, 2014. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA
Device class
Class III
The decision
- FDA number
- P140033
- Device name
- Assurity MRI and Endurity MRI Pacemakers, Tendril MRI Lead, MRI Activator, Merlin PCS Programer Software
- Applicant
- ABBOTT MEDICAL
- Applicant location
- Sylmar, CA
- Received
- Dec 24, 2014
- Decided
- Jan 31, 2017
- Decision
- Approved
- Supplements
- 100 in FDA's data for this PMA. See them on the FDA record
Device type
- Device class
- Class III
- Specialty
- CardiologyElectrophysiology
FDA's approval statement
As written in FDA's record.
Approval for the MR Conditional Pacemaker System (which includes the Assurity MRI (Models PM 1272, PM 2272) and Endurity MRI (Models PM 1172, PM 2172) pacemakers, Tendril MRI Lead (Model LPA 1200M), MRI Activator (Model EX4000), Merlin PCS Programmer Software (Model 3330 v 22.1.1), Merlin.net MN5000 7.4d, and Merlin@home EX2000 8.2.2). Implantation of a single-chamber pulse generator or dual-chamber pulse generator is indicated for in one or more of the following permananent conditions:1) Syncope;2) Presyncope;3) Fatigue;4) Disorientation; or5) Any combination of those symptomsMR Conditional pulse generator is safe for use in the MRI environment when used as a complete MR Conditional pacing system, and according to the instructions in the MRI Procedure Information document for the St. Jude Medical MR Conditional Pacing System. Rate-Modulated Pacing is indicated for patients with chronotropic incompetence, and for those who would benefit from increased stimulation rates concurrent with physical activity. Chronotropic incompetence has not been rigorously defined. A conservative approach, supported by the literature, defines chronotropic incompetence as the failure to achieve an intrinsic heart rate of 70% of the age-predicted maximum heart rate or 120 bpm during exercise testing, whichever is less, where the age-predicted heart rate is calculated as 197 (0.56 x age).Dual-Chamber Pacing (Dual-chamber pulse generators) is indicated for those patients exhibiting:1) Sick sinus syndrome2)Chronic, symptomatic second- and third-degree AV block3) Recurrent Adams-Stokes syndrome; and4) Symptomatic bilateral bundle branch block when tachyarrhythmia and other causes have been ruled out.Atrial Pacing is indicated for patients with sinus node dysfunction and normal AV and intraventricular conduction systems.Ventricular Pacing is indicated for patients with significant bradycardia and:1) Normal sinus rhythm with only rare episodes of A-V block or sinus arrest2) Chronic atrial fibrillation; and 3) Severe physical disabilityAF Suppression (Dual-chamber pulse generators) is indicated for suppression of paroxysmal or persistent atrial fibrillation episodes in patients with one or more of the above pacing indications.The Tendril MRI lead is a 7.9 French, transvenous, steroid eluting, bipolar, IS-1 compliant active fixation lead designed for permanent sensing and pacing in either the right atrium or the right ventricle, in combination with a compatible device. Active fixation leads such as the Tendril MRI lead may be indicated for patients where permanent fixation of passive fixation leads is suspected to be unstable.In atrial applications, the use of screw-in leads such as Tendril MRI lead may be indicated in the presence of an abnormal, surgically altered or excised atrial appendage.The MRI Activator handheld device is used to evaluate the status of, and to enable and disable, the previously stored MRI settings. The activator is intended for use with St. Jude Medical MR Conditional pulse generators.
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code LWP. The earliest in FDA's data is P780009, decided Mar 27, 1979.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
Other decisions for ABBOTT MEDICAL
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
P260019 · Decided Oct 27, 2026 · 180 days after receipt
Device type: Para-device leak occluder (SJT) · Cardiology
- EnSite X EP System510(k)
K261729 · Decided Sep 17, 2026 · 114 days after receipt
Device type: Computer, Diagnostic, Programmable (DQK) · Cardiology
- TactiFlex Duo Ablation Catheter, Sensor Enabled (A-TFDM-D, A-TFDM-F, A-TFDM-J, A-TFDM-DD, A-TFDM-DF, A-TFDM-FF, A-TFDMPMA supplement
P220013-S028 · Decided Sep 4, 2026 · 186 days after receipt · Panel Track
Device type: Catheter, percutaneous, cardiac ablation, for treatment of atrial fibrillation (OAE) · Cardiology
5 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.